BetaStem Therapeutics, Inc. , a pre-clinical biotechnology company focused on a curative treatment for diabetic retinopathy and diseases related to vascular damage , has retained Conditas Biotechnology Group, LLC for its services in the area of business development and corporate strategy.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130718005041&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130718005041&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment